Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.
2011-04-29
Registered
NEUVITAL V Study
2011-04-30
Registered
Change in Manufacture Process of Heberbiovac HB vaccine.
2011-04-30
Registered
GrUVen-I Study
2011-05-03
Registered
EGFpeeling I
2011-05-03
Registered
Clinical Trial Heberbiovac HB vaccine Material Reference Batch
2011-05-16
Registered
NASVAC therapeutic vaccine study
2011-05-16
Registered
Heberprovac Study
2011-05-16
Registered
TS-FARMEV Study
2011-05-16
Registered
Gamma IFN in Idiopathic Pulmonary Fibrosis.
2011-05-17
Registered
CERVISEG-300-I Study
2011-05-17
Registered
InMuMyel I Study
2011-05-19
Registered
HeberproGen Study
2011-05-20
Registered
SOFIA Study
2011-05-24
Registered
INJURE Study
2011-07-11
Registered
MAGINC Study
2011-07-12
Registered
Teravac HIV in chronic HIV-1.
2011-08-10
Registered
THERESA-4 Study
2011-10-25
Registered
HeberPAG® in Mycosis Fungoides (MYFIC Study)
2012-06-08
Registered
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series
2012-09-12
Registered
« first
‹ previous
1
2
3
4
5
6
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform